Document Type
Blog Post
Publication Date
10-21-2022
Digital USD Citation
Serbin, Kenneth P. PhD, "After abrupt shutdown of Triplet Therapeutics, Huntington’s disease community regroups in the fight for therapies" (2022). At Risk for Huntington's Disease. 332.
https://digital.sandiego.edu/huntingtons/332
COinS